Citation: | ZHAO Guo-bin, WANG Yu, TANG Yu-hong, et al. The Optimal Surgical Margins of Nephron-sparing Surgery for Stage T1b Renal Tumors[J]. Journal of Sichuan University (Medical Sciences), 2020, 51(4): 552-555. DOI: 10.12182/20200760504 |
[1] |
LEBACLE C, POOLI A, BESSEDE T, et al. Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art. World J Urol,2019,37(1): 115–123. DOI: 10.1007/s00345-018-2355-y
|
[2] |
EDGE S B, COMPTON C C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol,2010,17(6): 1471–1474. DOI: 10.1245/s10434-010-0985-4
|
[3] |
CAPITANIO U, TERRONE C, AATONELLI A, et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol,2015,67(4): 683–689. DOI: 10.1016/j.eururo.2014.09.027
|
[4] |
COOPERBERG M R, MALLIN K, KANE C J, et al. Treatment trends for stage I renal cell carcinoma. J Urol,2011,186(2): 394–399. DOI: 10.1016/j.juro.2011.03.130
|
[5] |
ZHANG K, XIE W L. Determination of the safe surgical margin for T1b renal cell carcinoma. Urol J,2017,14(1): 2961–2967.
|
[6] |
KUTIKOV A, UZZO R G. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol,2009,182(3): 844–853. DOI: 10.1016/j.juro.2009.05.035
|
[7] |
FERLAY J, SHIN H R, BRAY F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer,2010,127(12): 2893–2917. DOI: 10.1002/ijc.25516
|
[8] |
SHIN S J, KO K J, KIM T S, et al. Trends in the use of nephron-sparing surgery over 7 years: an analysis using the R.E.N.A.L. nephrometry scoring system. PLoS One,2015,10(11): e0141709[2019-07-02]. https://doi.org/10.1371/journal.pone.0141709.
|
[9] |
晁流, 刘宁, 甘卫东, 等. 保留肾单位术与根治性肾切除术对肾功能影响的比较. 中华腔镜泌尿外科杂志(电子版),2017,11(6): 393–397. DOI: 10.3877/cma.j.issn.1674-3253.2017.06.009
|
[10] |
LEIBOVICH B C, BLUTE M, CHEVILLE J C, et al. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol,2004,171(3): 1066–1070. DOI: 10.1097/01.ju.0000113274.40885.db
|
[11] |
LEE H J, LISS M A, DERWEESH I H. Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors. Curr Opin Urol,2014,24(5): 448–452. DOI: 10.1097/MOU.0000000000000081
|
[12] |
ZUCCHI A, MEARINI L, MEARINI E, et al. Renal cell carcinoma: histological findings on surgical margins after nephron sparing surgery. J Urol,2003,169(3): 905–908. DOI: 10.1097/01.ju.0000046779.58281.c4
|
[13] |
AKCETIN Z, ZUGOR V, ELSASSER D, et al. Does the distance to normal renal parenchyma (DTNRP) in nephron-sparing surgery for renal cell carcinoma have an effect on survival? Anticancer Res,2005,25(3A): 1629–1632.
|
[14] |
秦晓健, 张海梁, 叶定伟, 等. 临床T1b期肾癌选择性保留肾单位手术分析. 中华泌尿外科杂志,2013,34(3): 167–170. DOI: 10.3760/cma.j.issn.1000-6702
|
[15] |
CHEN X S, ZHANG Z T, DU J, et al. Optimal surgical margin in nephron-sparing surgery for T1b renal cell carcinoma. Urology,2012,79(4): 836–839. DOI: 10.1016/j.urology.2011.11.023
|
[16] |
RICHSTONE L, SCHERR D S, REUTER V R, et al. Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. J Urol,2004,171(2 Pt 1): 615–620. DOI: 10.1097/01.ju.0000106955.19813.f6
|
[17] |
SARGIN S Y, EKMEKCIOGLU O, ARPALI E, et al. Multifocality incidence and accompanying clinicopathological factors in renal cell carcinoma. Urol Int,2009,82(3): 324–329. DOI: 10.1159/000209366
|
[18] |
SIRACUSANO S, NOVARA G, ANTONELLI A, et al. Prognostic role of tumourmultifocality in renal cell carcinoma. BJU Int,2012,110(11 Pt B): E443–E448. DOI: 10.1111/j.1464-410X.2012.11121.x
|
[19] |
LI G, LUO Q, LANG Z, et al. Histopathologic analysis of stage pT1b kidney neoplasms for optimal surgical margins of nephron-sparing surgery. Clin Trans Oncol,2018,20(9): 1196–1201. DOI: 10.1007/s12094-018-1845-0
|
1. |
韩明,燕群峰,叶明宝,王亚辉,杜昌国,王延滨,任磊. 保留肾单位手术在局限性肾癌患者中的应用效果. 癌症进展. 2022(01): 74-76+92 .
![]() | |
2. |
扈新,张玉泉,杨志平,郭志全,王海临. 后腹腔镜下保留肾单位手术与肾根治性切除术治疗T1b期肾肿瘤的近远期效果对比. 国际泌尿系统杂志. 2021(03): 431-434 .
![]() |